⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Exogenous Ketones (Ketone Monoesters)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-03 — Aging microenvironment induces CD8T cell exhaustion by suppressing hepatic β-hydroxybutyrylate synthesis.: cross-connection with beta-hydroxybutyrate-3hb: Shares the mechanistic rationale that raising circulating 3HB could restore age-depleted immune function via PRKAR1B β-hydroxybutyrylation. (novelty: 4)
- 2026-07-21 — Do Ketone Drinks Improve Immune, Metabolic and Cognitive Health in Older Adults: cross-connection with ketone-monoester: Same intervention class — ketone monoester drinks are the specific compound tested under the broader exogenous ketones page; the older-adult RCT should be surfaced on both. (novelty: 3)
- 2026-09-09 — Targeting Aging With a Ketone Ester for Function in Frailty: cross-connection with ketone-esters: Ketone ester trial for frailty overlaps with the broader exogenous ketones page; both cover ester-based ketone delivery but from different angles (frailty endpoint vs. general ketone monoester pharmacology). (novelty: 4)
- 2026-07-02 — Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?: Registered early-phase clinical trial (DeltaG ketone monoester, single acute dose) in older adults with prediabetes vs normoglycemic controls, testing brain glucose uptake (FDG-PET) and cognitive processing speed — protocol only, no results yet. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?
02-jul-2026
novelty 3
per-area 3
strengthens